Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice

Resistant Hypertension

(2016) Adrian Doroszko et al.   Advances in Clinical and Experimental Medicine

Endothelial dysfunction in young healthy men is associated with aspirin resistance

(2015) Adrian Doroszko et al.   VASCULAR PHARMACOLOGY

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors

(2014) Yasuo Ikeda et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Role of Antihypertensive Drugs in Arterial ‘De-Stiffening’ and Central Pulsatile Hemodynamics

(2012) Charalambos Koumaras et al.   American Journal of Cardiovascular Drugs

Early Administration of Low-Dose Aspirin for the Prevention of Severe and Mild Preeclampsia: A Systematic Review and Meta-Analysis

(2012) Stéphanie Roberge et al.   AMERICAN JOURNAL OF PERINATOLOGY

Chronotherapy With Low-Dose Aspirin for Prevention of Complications in Pregnancy

(2012) Diana E. Ayala et al.   CHRONOBIOLOGY INTERNATIONAL

Comparison Between Zofenopril and Ramipril in Combination With Acetylsalicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a Randomized, Double-Blind, Parallel-Group, Multicenter, European Stud

(2012) Claudio Borghi et al.   CLINICAL CARDIOLOGY

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients

(2012) L. C. van Vark et al.   EUROPEAN HEART JOURNAL

Endothelial dysfunction and hypertension in aging

(2012) Yukihito Higashi et al.   HYPERTENSION RESEARCH

The Effects of Nonsteroidal Anti-Inflammatory Drugs on Blood Pressure in Hypertensive Patients

(2011) Stanley Snowden et al.   Cardiology in Review

Prostanoid Receptors

(2011) Takako Hirata et al.   CHEMICAL REVIEWS

Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease

(2011) Davide Capodanno et al.   Circulation-Cardiovascular Interventions

Aging and vascular endothelial function in humans

(2011) Douglas R. Seals et al.   CLINICAL SCIENCE

Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach

(2011) Uwe Zeymer et al.   CURRENT MEDICAL RESEARCH AND OPINION

Oxidative stress and endothelial dysfunction in hypertension

(2011) Eberhard Schulz et al.   HYPERTENSION RESEARCH

Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets

(2011) Grant R. Drummond et al.   NATURE REVIEWS DRUG DISCOVERY

COX-mediated endothelium-dependent contractions: from the past to recent discoveries

(2010) Michael Sze-Ka Wong et al.   ACTA PHARMACOLOGICA SINICA

Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

(2010) Phillip D. Levy et al.   AMERICAN HEART JOURNAL

Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway

(2010) John D. Hayes et al.   ANTIOXIDANTS & REDOX SIGNALING

From endothelial dysfunction to atherosclerosis

(2010) S. Sitia et al.   AUTOIMMUNITY REVIEWS

Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study

(2010) M. E. Molitch et al.   DIABETES CARE

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme

(2010) Su Min Chang et al.   EUROPEAN JOURNAL OF HEART FAILURE

Oxidative Stress and Endothelial Dysfunction in Aortas of Aged Spontaneously Hypertensive Rats by NOX1/2 Is Reversed by NADPH Oxidase Inhibition

(2010) Sven Wind et al.   HYPERTENSION

Role of the nitric oxide metabolic pathway and prostanoids in the pathogenesis of endothelial dysfunction and essential hypertension in young men

(2010) Adrian Doroszko et al.   HYPERTENSION RESEARCH

Macula Densa Sensing and Signaling Mechanisms of Renin Release

(2010) J. Peti-Peterdi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Aldosterone: effects on the kidney and cardiovascular system

(2010) Marie Briet et al.   Nature Reviews Nephrology

Endothelial dysfunction and vascular disease

(2009) P. M. Vanhoutte et al.   Acta Physiologica

Endothelial dysfunction and aging: An update

(2009) María Dolores Herrera et al.   AGEING RESEARCH REVIEWS

Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial†

(2009) Chris Adamopoulos et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prostanoids and reactive oxygen species: Team players in endothelium-dependent contractions

(2009) Eva H.C. Tang et al.   PHARMACOLOGY & THERAPEUTICS

Endothelium-dependent contractions: when a good guy turns bad!

(2008) Paul M. Vanhoutte et al.   JOURNAL OF PHYSIOLOGY-LONDON

Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients

(2008) Daniel Sacristán et al.   Proteomics Clinical Applications

Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS

(2007) J. H. O’Keefe et al.   DIABETES OBESITY & METABOLISM